Antigenics completes Aquila acquisition

AGEN completed its previously announced acquisition of AQLA for 2.5 million AGEN shares (0.2898 AGEN shares for each AQLA share), valued at $33.8 million based on AGEN's Thursday close of $13.50. The ...